MON-182 Increased Risk of Bleeding and Excessive Anticoagulation Using Standard Dose Low Molecular Weight Heparin (LMWH) in Cushing’s Syndrome

Background: Cushing’s Syndrome (CS) is a hypercoagulable state with increased risk of venous thrombosis events (VTE) including pulmonary embolism (PE) and deep venous thrombosis (DVT). In the absence of clear recommendations (1), a standard dose of low molecular weight heparin (LMWH) is given: 1 mg/...

Descripción completa

Detalles Bibliográficos
Autores principales: Haykal, Rasha, McGlotten, Raven, Bolan, Charles, Kalsi, Shelley, Nieman, Lynnette K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Adrenal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207365/
http://dx.doi.org/10.1210/jendso/bvaa046.1785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207365/
http://dx.doi.org/10.1210/jendso/bvaa046.1785

Ejemplares similares